Vascular remodelling in the embryo

From WikiMD's WELLNESSPEDIA

Vascular remodelling in the embryo is a critical process that involves the transformation of the primitive vascular network into a complex, hierarchically organized system of blood vessels. This process is essential for the proper development and function of the embryo and is regulated by a variety of molecular signals and mechanical forces.

Overview[edit]

The initial vascular network in the embryo is formed through a process known as vasculogenesis, where endothelial cells differentiate from angioblasts and coalesce to form a primitive vascular plexus. This plexus then undergoes extensive remodelling to form the mature vascular system, a process that involves the pruning of unnecessary vessels, the enlargement of others, and the formation of new branches through angiogenesis.

Regulation of Vascular Remodelling[edit]

Vascular remodelling is regulated by a complex interplay of molecular signals and mechanical forces. Key molecular regulators include vascular endothelial growth factor (VEGF) and angiopoietins, which promote endothelial cell proliferation and migration, and Notch signaling, which regulates the specification of arterial and venous identities.

Mechanical forces, such as blood flow and shear stress, also play a crucial role in vascular remodelling. These forces influence the behaviour of endothelial cells and contribute to the patterning of the vascular network.

Clinical Significance[edit]

Defects in vascular remodelling can lead to a variety of congenital heart diseases and other vascular anomalies. Understanding the mechanisms underlying vascular remodelling is therefore crucial for the development of therapeutic strategies for these conditions.

See Also[edit]

References[edit]

External Links[edit]

This article is a stub related to anatomy. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.